Laminin Receptors in the CNS and Vasculature

Laminin exerts a variety of important functions via binding to its receptors, including integrins and dystroglycan. With the advance in gene-targeting technology, many integrin/dystroglycan knockout/mutant mice were generated in the past 3 decades. These mutants enable loss-of-function studies and h...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 56; no. 8; pp. 2348 - 2359
Main Author Yao, Yao
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.08.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Laminin exerts a variety of important functions via binding to its receptors, including integrins and dystroglycan. With the advance in gene-targeting technology, many integrin/dystroglycan knockout/mutant mice were generated in the past 3 decades. These mutants enable loss-of-function studies and have substantially enriched our knowledge of integrin/dystroglycan functions. In this review, we summarize the functions of laminin receptors during embryonic development and in the central nervous system and vasculature. First, the biochemical properties of integrins and dystroglycan are briefly introduced. Next, we discuss loss-of-function studies on laminin receptors, including integrin-α3, integrin-α6, integrin-α7, integrin-β1, integrin-β4, and dystroglycan, focusing on embryonic development, the central nervous system, and vasculature. The phenotypes of compound knockout mice are described and compared with that of single mutants. Last, important questions and challenges in the field as well as potential future directions are discussed. Our goal is to provide a synthetic review on loss-of-function studies of laminin receptors in the central nervous system and vasculature, which could serve as a reference for future research, encourage the formation of new hypotheses, and stimulate new research in this field.
Bibliography:For Sources of Funding and Disclosures, see page 2357. Correspondence to: Yao Yao, PhD, Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd, MDC 8, Tampa, FL 33612. Email yao7@usf.edu
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0039-2499
1524-4628
1524-4628
DOI:10.1161/STROKEAHA.125.051560